QA: Biodelivery Sciences International INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001103021_2015_Biodelivery_Sciences_International_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001103021, Biodelivery Sciences International INC

  xvar xval
0 AssetsCurrent 78,323,000
1 IntangibleAssetsNetIncludingGoodwill 6,941,000
2 PropertyPlantAndEquipmentNet 3,890,000
3 remainder_Assets 157,000
4 LiabilitiesCurrent 29,201,000
5 LiabilitiesNoncurrent 700,000
6 remainder_Liabilities 5,014,000
7 CostOfGoodsAndServicesSold 5,895,560
8 SellingGeneralAndAdministrativeExpense 168,180,913
9 ResearchAndDevelopmentExpense 28,603,136
10 remainder_Expenses 3,630
11 remainder_Revenues 25,191,211
12 remainder_NetIncome -1,027,239
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 89,311,000
1 Liabilities 34,915,000
2 Expenses 202,683,239
3 Revenues 25,191,211
4 StockholdersEquity 54,396,000
5 NetIncome -178,519,267
6 ComprehensiveNetIncome -178,519,267
7 BaseVar 176,563,844
8 EconomicCapitalRatiobeforeLimitedLiability -0.965
9 EconomicCapitalRatio 1.31

Edgar->Model Mapping

Feature Distribution

Change over Time